Description

DNA sequencing is a laboratory technique used to determine the exact sequence of bases (A, C, G, and T) in a DNA molecule. The DNA base sequence carries the information a cell needs to assemble protein and RNA molecules. DNA sequence information is important to scientists investigating the functions of genes. A study by StrategyHelix indicates that the global DNA sequencing market is expected to increase by US$ 28.7 billion from 2022 to 2028, garnering a CAGR of 18.1% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for DNA sequencing. The global DNA sequencing market is segmented on the basis of product, sequencing type, application, and region. Based on product, the global DNA sequencing market is categorized into sequencing services, sequencing instruments, sequencing consumables, sequencing informatics. Sequencing services held the highest share in the global dna sequencing market. However, the sequencing informatics segment is forecast to register the highest CAGR during the forecast period 2022 – 2028. On the basis of sequencing type, the global DNA sequencing market has been segmented into next generation sequencing (NGS), sanger sequencing, others. The NGS segment captured the largest share of the market in 2021. By application, the global DNA sequencing market has been segmented into applied, clinical, research. In terms of geography, the global DNA sequencing market has been segmented into Asia Pacific, Europe, North America, Rest of the World (RoW). North America held the largest revenue share in 2021.

The global DNA sequencing market is highly competitive. As of 2021, the major players in the global DNA sequencing market were Adaptive Biotechnologies Corp., Agilent Technologies Inc., Ambry Genetics Corporation, BD (Becton Dickinson and Company), Berry Genomics Co. Ltd., BGI Group, Biodesix Inc., CareDx Inc., Centogene AG, Danaher Corporation, Devyser Diagnostics AB, Illumina Inc., Macrogen Inc., Merck KGaA, myDNA Inc., Natera Inc., NeoGenomics Laboratories Inc., New England Biolabs Inc., NGeneBio Co. Ltd., Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., PerkinElmer Inc., Personalis Inc., Qiagen N.V., Quest Diagnostics Inc., Roche Holding AG, SOPHiA GENETICS, TAKARA BIO INC., Thermo Fisher Scientific Inc.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the DNA sequencing market to help drive informed decision making for industry executives, policy makers, academic, and analysts.


Report Scope

Product: sequencing services, sequencing instruments, sequencing consumables, sequencing informatics
Sequencing type: next generation sequencing (NGS), sanger sequencing, others
Application: applied, clinical, research
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028


Key Benefits for Stakeholders

– Get a comprehensive picture of the global DNA sequencing market
– Pinpoint growth sectors and trends for investment


Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. DNA sequencing market overview
Part 3. Market breakdown by product
– Sequencing services
– Sequencing instruments
– Sequencing consumables
– Sequencing informatics
Part 4. Market breakdown by sequencing type
– Next generation sequencing (NGS)
– Sanger sequencing
– Others
Part 5. Market breakdown by application
– Applied
– Clinical
– Research
Part 6. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 7. Key companies
– Adaptive Biotechnologies Corp.
– Agilent Technologies, Inc.
– Ambry Genetics Corporation
– BD (Becton, Dickinson and Company)
– Berry Genomics Co., Ltd.
– BGI Group
– Biodesix, Inc.
– CareDx, Inc.
– Centogene AG
– Danaher Corporation
– Devyser Diagnostics AB
– Illumina, Inc.
– Macrogen, Inc.
– Merck KGaA
– myDNA Inc.
– Natera, Inc.
– NeoGenomics Laboratories, Inc.
– New England Biolabs, Inc.
– NGeneBio Co., Ltd.
– Oxford Nanopore Technologies Limited
– Pacific Biosciences of California, Inc.
– PerkinElmer, Inc.
– Personalis, Inc.
– Qiagen N.V.
– Quest Diagnostics Inc.
– Roche Holding AG
– SOPHiA GENETICS
– TAKARA BIO INC.
– Thermo Fisher Scientific Inc.
About StrategyHelix
Disclaimer


USD 850

Product Type

Industry Briefing

Release Date

April 2022

Region

Global

Pages

18

REQUEST SAMPLE

Global DNA Sequencing Market 2022

Please fill out our form and we will get back to you.

CUSTOM RESEARCH

Global DNA Sequencing Market 2022

Please fill out our form and we will get back to you.

login